The Senhance by TransEnterix Receives Japan Approval!!!

anonymous

Guest
In today’s healthcare environment, cost is of utmost importance. Huge news!!! Japan’s high penetration of laparoscopic surgery coupled with their rapid adoption of robotics and the intense focus on procedure cost creates a considerable market opportunity for Senhance.
 






In today’s healthcare environment, cost is of utmost importance. Huge news!!! Japan’s high penetration of laparoscopic surgery coupled with their rapid adoption of robotics and the intense focus on procedure cost creates a considerable market opportunity for Senhance.

https://finance.yahoo.com/news/transenterix-inc-trxc-q1-2019-042403361.html

Don’t believe the BS. This company is one step away from dead.
They haven’t sold a robot in the US in 7 months now and counting. Only sold 4 robots in the US in the past 18months. Their Global revenue for q1 2019 was 2.2 M. Very pathetic.

Pay attention to new technology coming out from CMR, Intuitive, etc...